Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Immune monitoring

Rapid screening for safe, responsive immunotherapy treatment

Immune monitoring

Immune monitoring for patients receiving cancer immunotherapy is vital for understanding the process and efficacy throughout the course of the treatment. Characterizing the immune status for insights into the therapy’s potential is essential, particularly in patients who are receiving novel immune-modulating therapies. Speed and efficiency of immune assays allow for real-time feedback and the ability to be agile in a patient’s treatment regimen.

Immune Monitoring

Enable rapid screening and design

The BioXp™ system’s high-throughput gene synthesis and flexible cloning modalities enable rapid screening and design of novel chimeric antigen receptors (CARs), engineered TCRs, and artificial transcription factors, thus supporting the investigation of different CAR designs to enhance their tumor specificity, or to fine-tune T cell activity. Further, the development of novel gene circuits or CARs to increase effectiveness of CAR-T therapy by engineering T cell mobility or mitigating immunosuppressive cues in the cancer microenvironment can help drive improved efficacy.

Learn more

Contact us

The expertise of our scientists, engineers, and supporting teams is always available. Or call us: 858.228.4115

By clicking Submit, you agree that Codex DNA may use this information to contact you about our programs, products, or services. You may opt out at any time.

Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them. We never sell your data to anyone.